BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4718463)

  • 21. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 1. Anti-inflammatory, analgesic and antipyretic properties.
    Bianchi C; Lumachi B; Marazzi-Uberti E
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:183+. PubMed ID: 5067190
    [No Abstract]   [Full Text] [Related]  

  • 22. 2-Phenyl-4H-cyclopentathiazole-4-carboxylic acids as potential antiinflammatory agents.
    McEvoy FJ; Allen GR
    J Med Chem; 1972 Aug; 15(8):850-1. PubMed ID: 5044301
    [No Abstract]   [Full Text] [Related]  

  • 23. 4-Amino-5-arylpyrimidines as antiinflammatory agents.
    Lang SA; Cohen E
    J Med Chem; 1975 Jun; 18(6):623-5. PubMed ID: 1151980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological properties of thiazolinobutazone (LAS 11871). I. Anti-inflammatory effects.
    Márquez M; Roberts DJ
    Arzneimittelforschung; 1974 Nov; 24(11):1786-9. PubMed ID: 4480050
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacological studies of Bufexamac topically applied on the skin.
    Lambelin G; Vassart-Thys D; Roba J
    Arch Int Pharmacodyn Ther; 1970 Oct; 187(2):401-14. PubMed ID: 5481488
    [No Abstract]   [Full Text] [Related]  

  • 26. Structure-activity relationships in a series of anti-inflammatory N-arylanthranilic acids.
    Kaltenbronn JS; Scherrer RA; Short FW; Jones EM; Beatty HR; Saka MM; Winder CV; Wax J; Williamson WR
    Arzneimittelforschung; 1983; 33(4A):621-7. PubMed ID: 6683967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiinflammatory activity of alpha-methyl-3-phenyl-7-benzofuranacetic acid (R-803).
    Swingle KF; Scherrer RA; Grant TJ
    Arch Int Pharmacodyn Ther; 1975 Apr; 214(2):240-9. PubMed ID: 1156032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-inflammatory activity of N-ethoxycarbonyl-3-benzoyltrifluoromethanesulfonanilide (MBR 4223, triflumidate), a new nonsteroidal compound.
    Swingle KF; Harrington JK; Hamilton RR; Kvam DC
    Arch Int Pharmacodyn Ther; 1971 Jul; 192(1):16-25. PubMed ID: 5093187
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pharmacologic properties of a new, nonsteroidal anti-inflammatory agent, bucloxic acid (804 CB)].
    Navarro J; Stoliaroff M; Savy JM; Berny C; Brunaud M
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1368-78. PubMed ID: 4480066
    [No Abstract]   [Full Text] [Related]  

  • 30. USE OF TIME-RESPONSE RELATIONSHIPS IN ASSESSING PHARMACOLOGICAL ACTIVITY.
    BRITTAIN RT; SPENCER PS
    J Pharm Pharmacol; 1965 Jun; 17():389-91. PubMed ID: 14324466
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pharmacotherapy in uratic arthritis. I].
    Alvsaker JO
    Tidsskr Nor Laegeforen; 1977 May; 97(13):656. PubMed ID: 867359
    [No Abstract]   [Full Text] [Related]  

  • 32. Structure-activity relationships among some antiinflammatory 3-(5-aryl-2-tetrazolyl)alkanoic acids and derivatives.
    Buckler RT
    J Med Chem; 1972 Jun; 15(6):578-83. PubMed ID: 5030919
    [No Abstract]   [Full Text] [Related]  

  • 33. [Local anti-inflammatory and anti-actinic action of oil extracted from Plantago sp. seeds].
    Moisă L; Dobre A; Mihalydeakpal E
    Rev Med Chir Soc Med Nat Iasi; 1975; 79(4):585-7. PubMed ID: 1224056
    [No Abstract]   [Full Text] [Related]  

  • 34. Proceedings: A novel method for evaluating anti-inflammatory drugs in the conscious guinea pig.
    McDonald-Gibson WJ; Schneider C
    Br J Pharmacol; 1974 Sep; 52(1):149P. PubMed ID: 4451800
    [No Abstract]   [Full Text] [Related]  

  • 35. A naproxen symposium: introduction.
    Brass A
    J Clin Pharmacol; 1975 Apr; 15(4 Pt. 2):309-10. PubMed ID: 1127134
    [No Abstract]   [Full Text] [Related]  

  • 36. The relationship between development of ultraviolet erythema and release of prostaglandins in guinea pig skin.
    Adams SS; Humphries RG; Mason CG
    Agents Actions; 1981 Nov; 11(5):473-6. PubMed ID: 7337071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production of ultraviolet-light-induced skin erythema in the hairless rat: a comparison with the haired rat in screening for anti-inflammatory drugs.
    Fox PK; Lewis AJ
    Lab Anim; 1979 Oct; 13(4):321-3. PubMed ID: 529769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 4-oxo-1,2,3,4-tetrahydroquinazolines. I. Syntheses and pharmacological properties of 2-methyl-3-aryl-4-oxo-1,2,3,4-tetrahydroquinazolines and their 1-acyl derivatives.
    Okumura K; Oine T; Yamada Y; Hayashi G; Nakama M
    J Med Chem; 1968 Mar; 11(2):348-52. PubMed ID: 4385706
    [No Abstract]   [Full Text] [Related]  

  • 39. Delay of erythema of human skin by anti-inflammatory drugs after ultraviolet irradiation.
    Gruber CM; Ridolfo AS; Nickander R; Mikulaschek WM
    Clin Pharmacol Ther; 1972; 13(1):109-13. PubMed ID: 5008187
    [No Abstract]   [Full Text] [Related]  

  • 40. Knowledge of body site variability in ultraviolet-induced erythemal responses guides choice of site for pre-therapy minimal erythema dose testing.
    Dawe RS
    J Invest Dermatol; 2005 Mar; 124(3):662; author reply 663. PubMed ID: 15737209
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.